163 related articles for article (PubMed ID: 2903712)
1. Plasma sex steroid transport and histamine H2-receptor antagonists. Clinical implications.
Berta L; Dusio P; Fortunati N; Fazzari A; Crua MR; Frairia R; Gaidano G
Ann N Y Acad Sci; 1988; 538():304-12. PubMed ID: 2903712
[No Abstract] [Full Text] [Related]
2. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
De Natale G; De Natale F; Marino A
Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
[TBL] [Abstract][Full Text] [Related]
3. [H2 receptor antagonists and intragastric acidity].
Dammann HG; Walter TA; Müller P; Simon B
Dtsch Med Wochenschr; 1984 Nov; 109(46):1767-9. PubMed ID: 6094136
[No Abstract] [Full Text] [Related]
4. Frequent non-response to histamine H2-receptor antagonists in cirrhotics.
Walker S; Krishna DR; Klotz U; Bode JC
Gut; 1989 Aug; 30(8):1105-9. PubMed ID: 2570008
[TBL] [Abstract][Full Text] [Related]
5. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.
Howard JM; Chremos AN; Collen MJ; McArthur KE; Cherner JA; Maton PN; Ciarleglio CA; Cornelius MJ; Gardner JD; Jensen RT
Gastroenterology; 1985 Apr; 88(4):1026-33. PubMed ID: 2857672
[TBL] [Abstract][Full Text] [Related]
6. Comparison of famotidine with cimetidine and ranitidine.
Berardi RR; Tankanow RM; Nostrant TT
Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
[TBL] [Abstract][Full Text] [Related]
7. Famotidine: effective treatment of Zollinger-Ellison syndrome.
Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
[TBL] [Abstract][Full Text] [Related]
8. Effects of short- and long-term administrations of famotidine and ranitidine on some pituitary, sexual and thyroid hormones.
Corinaldesi R; Pasquali R; Paternico A; Stanghellini V; Paparo GF; Ricci Maccarini M; Barbara L
Drugs Exp Clin Res; 1987; 13(10):647-54. PubMed ID: 2892657
[TBL] [Abstract][Full Text] [Related]
9. Clinical importance of the new H2-antagonists.
Walt RP
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():97-9. PubMed ID: 2566730
[TBL] [Abstract][Full Text] [Related]
10. Famotidine in the therapy of gastric hypersecretory states.
Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
[TBL] [Abstract][Full Text] [Related]
11. [Histamine H2-receptor antagonists as new anti-ulcer agents].
Takemoto T
Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
[No Abstract] [Full Text] [Related]
12. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
Miagkova LP; Grebenev AL; Kkhorshed AM
Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773
[No Abstract] [Full Text] [Related]
13. Recurrent parotitis with H2 receptor antagonists in a patient with Sjogren's syndrome.
Tomasko MA; Luskin AT
Am J Med; 1988 Aug; 85(2):271. PubMed ID: 2899973
[No Abstract] [Full Text] [Related]
14. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical effects and problems; histamine H2 receptor blockaders].
Tani N; Miwa T
Nihon Rinsho; 1988 Jan; 46(1):12-7. PubMed ID: 2897482
[No Abstract] [Full Text] [Related]
15. Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.
Campoli-Richards DM; Clissold SP
Drugs; 1986 Sep; 32(3):197-221. PubMed ID: 2875864
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of H2-receptor antagonists: an overview.
Schunack W
J Int Med Res; 1989; 17 Suppl 1():9A-16A. PubMed ID: 2566544
[TBL] [Abstract][Full Text] [Related]
18. Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience.
Bianchi Porro G
Digestion; 1985; 32 Suppl 1():62-9. PubMed ID: 2866137
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of famotidine and ranitidine in duodenal ulcer].
Rohner HG; Gugler R; Kimmig JM; Schönekäs H
Dtsch Med Wochenschr; 1987 Feb; 112(9):367-8. PubMed ID: 2880704
[No Abstract] [Full Text] [Related]
20. Famotidine: clinical applications of a new H2-receptor antagonist. May 16, 1986, Carmel, California.
Am J Med; 1986 Oct; 81(4B):1-64. PubMed ID: 2877568
[No Abstract] [Full Text] [Related]
[Next] [New Search]